XML 62 R55.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-Based Compensation - Summary of Stock Incentive Plans Activity (Detail)
6 Months Ended
Jul. 13, 2024
$ / shares
shares
Restricted Stock Awards [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Outstanding, Beginning balance | shares 819,457
Granted | shares 0
Vested | shares (460,364)
Cancelled/Forfeited | shares (12,981)
Outstanding, Ending balance | shares 346,112
Weighted Average Grant-Date Fair Value, Beginning balance | $ / shares $ 24.92
Weighted Average Grant-Date Fair Value, Granted | $ / shares 0
Weighted Average Grant-Date Fair Value, Vested | $ / shares 23.16
Weighted Average Grant-Date Fair Value, Cancelled/Forfeited | $ / shares 26.77
Weighted Average Grant-Date Fair Value, Ending balance | $ / shares $ 27.19
Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Outstanding, Beginning balance | shares 0
Granted | shares 580,063
Vested | shares (15,490)
Cancelled/Forfeited | shares (11,631)
Outstanding, Ending balance | shares 552,942
Weighted Average Grant-Date Fair Value, Beginning balance | $ / shares $ 0
Weighted Average Grant-Date Fair Value, Granted | $ / shares 20.29
Weighted Average Grant-Date Fair Value, Vested | $ / shares 20.41
Weighted Average Grant-Date Fair Value, Cancelled/Forfeited | $ / shares 20.41
Weighted Average Grant-Date Fair Value, Ending balance | $ / shares $ 20.28
Performance Share Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Outstanding, Beginning balance | shares 290,310
Granted | shares 413,207
Vested | shares 0
Cancelled/Forfeited | shares (10,294)
Outstanding, Ending balance | shares 693,223
Weighted Average Grant-Date Fair Value, Beginning balance | $ / shares $ 27
Weighted Average Grant-Date Fair Value, Granted | $ / shares 20.53
Weighted Average Grant-Date Fair Value, Vested | $ / shares 0
Weighted Average Grant-Date Fair Value, Cancelled/Forfeited | $ / shares 23.39
Weighted Average Grant-Date Fair Value, Ending balance | $ / shares $ 23.2